Characterization and clinical outcomes of low hormonal receptor positive / HER2 negative early breast cancer

被引：0
|
作者：
Karnmanee, J. [1 ]
Dajsakdipon, T. [2 ]
Sripaiboonkij, N. [3 ]
Dejthevaporn, T. [2 ]
机构：
[1] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok, Thailand
[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok, Thailand
[3] Mahidol Univ, Ramathibodi Hosp, Fac Med, Ramathibodi Comprehens Canc Ctr, Bangkok, Thailand
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.240
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
299P
引用
收藏
页码：S340 / S340
页数：1
相关论文
共 50 条
  • [41] Prospective Validation and Characterization of HER2 Positive Circulating Tumor Cells in Patients with HER2 Negative Metastatic Breast Cancer.
    Olson, E. M.
    Flores, L. M.
    Najita, J. S.
    Curley, C.
    Jeong, J.
    Murray, K.
    Savoie, J. J.
    Winer, E. P.
    Krop, I. E.
    CANCER RESEARCH, 2011, 71
  • [42] The association of HER2 low expression with the efficacy of CDK4/6 inhibitor in hormone receptor positive HER2 negative metastatic breast cancer.
    Bao, Kelvin K. H.
    Sutanto, Leone
    Tse, Shirley S. W.
    Cheung, Ka Man
    Chan, Jeffrey C. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancer
    Christian F. Singer
    Daphne Gschwantler-Kaulich
    Anneliese Fink-Retter
    Georg Pfeiler
    Ingrid Walter
    Gernot Hudelist
    Samir Helmy
    Anne-Catherine Spiess
    Wolfgang Lamm
    Ernst Kubista
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 807 - 813
  • [44] HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancer
    Singer, Christian F.
    Gschwantler-Kaulich, Daphne
    Fink-Retter, Anneliese
    Pfeiler, Georg
    Walter, Ingrid
    Hudelist, Gernot
    Helmy, Samir
    Spiess, Anne-Catherine
    Lamm, Wolfgang
    Kubista, Ernst
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (06) : 807 - 813
  • [45] HER2 equivocal breast cancer that is positive by alternative probe HER2 FISH are classified as HER2 negative by Oncotype DX
    Tozbikian, Gary H.
    Zynger, Debra L.
    BREAST JOURNAL, 2018, 24 (04): : 535 - 540
  • [46] Characteristics, treatment and outcomes of HER2 positive male breast cancer
    Esposito, Adrienne
    Ablah, Elizabeth
    Okut, Hayrettin
    Tenofsky, Patty L.
    AMERICAN JOURNAL OF SURGERY, 2023, 225 (03): : 489 - 493
  • [47] EZH2 protein expression in early hormone receptor positive HER2 negative breast cancer with high recurrence score
    Lin, Shuwen
    Lo, Yungtai
    Makower, Della
    Lu, Jinyu
    Fineberg, Susan
    CANCER RESEARCH, 2024, 84 (09)
  • [48] Quantitative assessment of HER2 amplification in HER2-positive breast cancer: its association with clinical outcomes
    Qijia Xuan
    Hongfei Ji
    Xuanchen Tao
    Yongpeng Xu
    Qingyuan Zhang
    Breast Cancer Research and Treatment, 2015, 150 : 581 - 588
  • [49] Quantitative assessment of HER2 amplification in HER2-positive breast cancer: its association with clinical outcomes
    Xuan, Qijia
    Ji, Hongfei
    Tao, Xuanchen
    Xu, Yongpeng
    Zhang, Qingyuan
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (03) : 581 - 588
  • [50] Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience
    Pizzuti, Laura
    Giordano, Antonio
    Michelotti, Andrea
    Mazzotta, Marco
    Natoli, Clara
    Gamucci, Teresa
    De Angelis, Claudia
    Landucci, Elisabetta
    Diodati, Lucrezia
    Iezzi, Laura
    Mentuccia, Lucia
    Fabbri, Agnese
    Barba, Maddalena
    Sanguineti, Giuseppe
    Marchetti, Paolo
    Tomao, Silverio
    Mariani, Luciano
    Paris, Ida
    Lorusso, Vito
    Vallarelli, Simona
    Cassano, Alessandra
    Airoldi, Francesca
    Orlandi, Armando
    Moscetti, Luca
    Sergi, Domenico
    Sarobba, Maria Giuseppina
    Tonini, Giuseppe
    Santini, Daniele
    Sini, Valentina
    Veltri, Enzo
    Vaccaro, Angela
    Ferrari, Laura
    De Tursi, Michele
    Tinari, Nicola
    Grassadonia, Antonino
    Greco, Filippo
    Botticelli, Andrea
    La Verde, Nicla
    Zamagni, Claudio
    Rubino, Daniela
    Cortesi, Enrico
    Magri, Valentina
    Pomati, Giulia
    Scagnoli, Simone
    Capomolla, Elisabetta
    Kayal, Ramy
    Scinto, Angelo Fedele
    Corsi, Domenico
    Cazzaniga, Marina
    Laudadio, Lucio
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) : 7708 - 7717
12345